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Abstract
© 2014 The Authors. Mitochondria have long been known to be the gatekeepers of cell fate.
This is particularly so in the response to acute ischaemia-reperfusion injury (IRI). Following an
acute episode of sustained myocardial ischaemia, the opening of the mitochondrial permeability
transition pore (MPTP) in the first few minutes of reperfusion, mediates cell death. Preventing
MPTP opening at  the onset of  reperfusion using either pharmacological  inhibitors [such as
cyclosporin A (CsA)] or genetic ablation has been reported to reduce myocardial infarct (MI) size
in animal models of acute IRI. Interestingly, the endogenous cardioprotective intervention of
ischaemic conditioning, in which the heart is protected against MI by applying cycles of brief
ischaemia and reperfusion to either the heart itself or a remote organ or tissue, appears to be
mediated through the inhibition of MPTP opening at reperfusion. Small proof-of-concept clinical
studies  have demonstrated the translatability  of  this  therapeutic  approach to  target  MPTP
opening using CsA in clinical settings of acute myocardial IRI. However, given that CsA is a not a
specific MPTP inhibitor, more novel and specific inhibitors of the MPTP need to be discovered -
the molecular identification of the MPTP should facilitate this. In this paper, we review the role of
the MPTP as a target for cardioprotection, the potential mechanisms underlying MPTP inhibition
in  the  setting  of  ischaemic  conditioning,  and  the  translatability  of  MPTP  inhibition  as  a
therapeutic approach in the clinical setting.
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